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Background: Insulin resistance is strongly associated with the development of type 2 diabetes and cardiovascular
disease. However, the underlying mechanisms linking insulin resistance and the development of atherosclerosis
have not been fully elucidated. Moreover, the protective effect of antihyperglycemic agent, metformin, is not
fully understood. This study investigated the protective effects and underlying mechanisms of metformin in
balloon-injury induced stenosis in insulin resistant rats.
Methods: After 4 weeks high fructose diet, rats received balloon catheter injury on carotid arteries and were
sacrificed at 1 and 4 weeks post injury. Biochemical, histological, and molecular changes were investigated.
Results: Plasma levels of glucose, insulin, total cholesterol, triglyceride, free fatty acids, and methylglyoxal were
highly increased in fructose-induced insulin resistant rats and treatment with metformin significantly improved
this metabolic profile. The neointimal formation of the carotid arteries was enhanced, and treatment with
metformin markedly attenuated neointimal hyperplasia. A significant reduction in BrdU-positive cells in the
neointima was observed in the metformin-treated group (P < 0.01). Insulin signaling pathways were inhibited in
insulin resistant rats while treatment with metformin enhanced the expression of insulin signaling pathways.
Increased expression of JNK and NFKB was suppressed following metformin treatment. Vasoreactivity was
impaired while treatment with metformin attenuated phenylephrine-induced vasoconstriction and enhanced
methacholine-induced vasorelaxation of the balloon injured carotid arteries in insulin resistant rats.
Conclusion: The balloon-injury induced neointimal formation of the carotid arteries is enhanced by insulin resistance.
Treatment with metformin significantly attenuates neointimal hyperplasia through inhibition of smooth muscle cell
proliferation, migration, and inflammation as well as by improvement of the insulin signaling pathway.
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Insulin resistance is the key pathophysiological feature
of obesity and type 2 diabetes. Emerging evidence sug-
gests that insulin resistance is strongly associated with
the development of atherosclerosis and cardiovascular dis-
ease [1,2]. There is a strong association between reduced* Correspondence: qhmeng@mdanderson.org
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reproduction in any medium, provided the orinsulin sensitivity and carotid intima-media thickness [1].
Moreover, insulin resistance enhances neointimal hyper-
plasia after balloon injury in rats [3-5].
Methylglyoxal (MG) is an intermediate endogenous prod-
uct of glucose and fructose [6]. MG is highly elevated in
diabetes and is associated with the development of dia-
betic complications [7-9]. It has been shown that MG
administration induces atherosclerotic changes in rats
[10]. Substantial evidence suggests that increased dietary
consumption of fructose induces insulin resistance in
animals and humans [11-13]. Fructose-induced insulin
resistance has been well established and characterizedThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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fructose is a major precursor of MG [6,15]. Therefore,
there is likely an association between MG production
and the development of fructose-induced insulin resistance
and insulin resistance-associated atherosclerosis exists.
Metformin is an insulin-sensitizing agent with potent
antihyperglycemic properties. These properties of met-
formin are mainly attributed to suppression of hepatic
gluconeogenesis and to increased peripheral tissue insu-
lin sensitivity [16]. Metformin serves as the scavenger
of MG and reduces the rate of progression to type 2
diabetes in humans with obesity or impaired glucose
tolerance [17]. Metformin has long been known to reduce
the development of atherosclerotic lesions in animal
models, and clinical studies have shown the drug to re-
duce surrogate measures such as carotid intima-media
thickness [18].
However, little is known of the protective effects and
mechanismas of metformin on the pathogenesis of ath-
erosclerosis in insulin resistance. The aim of this study
was to investigate the protective effects of metformin and
the underlying mechanisms on balloon-injury induced
stenosis in fructose-induced insulin resistance.Methods
Chemicals
Unless otherwise specified, all chemicals were purchased
from Sigma-Aldrich (St. Louis, Mo., USA).Experimental design
All experiments were performed following the guidelines
of the Canadian Council on Animal Care and all experi-
mental protocols were approved by the Animal Research
Ethics Board at the University of Saskatchewan. After
one week of adaptation with regular diet, male Sprague–
Dawley (SD) rats (aged of 6 weeks and weighing 175 g)
were randomly assigned to one of two different groups
(n = 8 each): high fructose diet (60%, Harlan) (experimen-
tal) or normal chow diet (controls) with or without admin-
istration of metformin. Animals in the experimental group
were fed a fructose-rich diet (60%; Harlan) for 4 weeks
in order to induce insulin resistance [12,14]. In another
group, metformin (300 mg/kg/day in 3 g/L in drinking
water) was administered simultaneously throughout the
experimental period to rats receiving the high fructose
diet (60%; Harlan). Metformin was also given to a sub-
group of rats receiving normal chow diet. Rats were
housed in cages on a 12-hour light/dark cycle at ambi-
ent temperature (21-23°C), and relative humidity was
held at 55 ± 10% in the colony room. Water was given
ad libitum.
After 4 weeks of diet intervention, rats received carotid
balloon injury and were sacrificed at 1 and 4 weeks postballoon injury. The above diet regime was continued until
the end of the study.
Carotid artery balloon injury
After the 4-week dietary intervention, the balloon denuda-
tion injuries were performed in the rat carotid artery
following a previously described procedure [19]. Briefly,
a 2F Fogarty balloon embolectomy catheter (Baxter Health
Care Co, Toronto) was introduced into the left external
carotid artery and further into the common carotid to
denude the vessel of endothelium. Bromodeoxyuridine
(BrdU) (100 mg/kg) was given intraperitoneally 18 hours
before euthanization on day 7 after balloon injury for ana-
lysis of cellular proliferation in the various groups of rats.
The animals were euthanized with an overdose of pento-
barbital (200 mg/kg) at 1 or 4 weeks following balloon
injury and the carotid arteries were collected for analyses.
Metabolic measurements
After 10 hours of fasting, rats were anesthetised and blood
pressure was measured. Fasting blood (1 ml) was collected
through the abdominal vein to determine fasting glucose
and insulin levels prior to administering 1 U insulin/kg
of body weight via the portal vein for insulin tolerance
testing. The animals were euthanized with an overdose
of pentobarbital (200 mg/kg) 15 min after insulin was
given and the blood was collected. Plasma glucose and
lipid profiles were determined by enzymatic colorimet-
ric techniques on Roche Cobas 6000 (Roche Diagnostics,
USA). Plasma insulin was assayed using a commercially
available immunoassay kit by ELISA (Mercodia, Upsala,
Sweden). Non-esterified free fatty acids were measured
using a method described previously in our laboratory [20].
Plasma MG was measured by liquid chromatography-
tandem mass spectrometry (LC-MS/MS) [8].
Histological and morphometric analyses
Histological and morphometric analyses were performed
as described previously [19]. The carotid arteries were
perfusion fixed at a constant physiologic pressure of
125 mmHg with 4% paraformaldehyde. The carotid arter-
ies were carefully stripped of adventitia and excised be-
tween the origin at the aorta and the carotid bifurcation.
The cross-sections of carotid artery were stained with
hematoxylin and eosin and photographed. The intimal
and medial cross-sectional areas of the carotid arteries
were measured using an NIH Image 1.62 program and the
intima/media ratios of the cross-sections were calculated.
Immunohistological staining
After the collection of carotid arteries from the above,
the carotid artery was fixed in 4% paraformaldehyde
for 12 hours, embedded in paraffin and sectioned for
immunohistostaining. Detection of smooth muscle cell
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BrdU incorporation method as previously described [19].
Briefly, sections were incubated with monoclonal mouse
antibody against BrdU (1/10 dilution, Cat. No. 1-299-964,
Roche). Primary antibodies were detected using sheep anti-
mouse-Ig-alkaline phosphatase (1/10 dilution). Hematoxylin
was used for countstaining. Proliferation was determined
by calculating the BrdU labeling index expressed as the
ratio of BrdU-positive cells to total nucleated cells. Apoptosis
was also assessed using a terminal deoxynucleotidyl transfer-
ase (TdT)-mediated dUTP nick end-labeling (TUNEL)
apoptosis detection kit (Cat. No. 17–141, UPSTATE) [19].
Smooth muscle cell culture and wound assay
Smooth muscle cells (SMCs) were isolated from the
neointima of the injured carotid arteries of rats by en-
zymatic dispersion as described above [21]. To examine
the role of fructose and MG on the SMC response to
injury, we performed a scrape wound assay on confluent
SMCs grown in vitro - an assay that mimics the cell mi-
gration and proliferation occurring during intimal hyper-
plasia [21]. Cells were grown to confluence in a 6-well
tissue culture plate and then wounded with a P20 pipette
tip to create a lengthwise wound measuring ~300 μm in
width. Measurements of wound width were obtained every
24 hours over a period of 72 hours using Nikon NIS-
elements BR3.1. Mean values were expressed as a percent
of wound closure, which was calculated as follows: Percent
wound closure = 1 − (widtht/width0) × 100%.
Matrix metalloproteinase activity
To investigate whether matrix metalloproteinase (MMP)
could be involved, the effects of fructose and MG on
MMP activities were assessed in an in vitro experiment.
MMP activity was measured using gelatin zymography.
In brief, medial and neointimal SMCs were harvested and
seeded at a density of 60,000 cells/well in 96-well plates.
The cells were incubated with 10% FCS for 8 hours to
allow cell attachment. The cells were then serum starved
for 16 hours, followed by incubation with various concen-
trations of fructose or MG in 10% FCS for 24 hours. Con-
ditioned media from each well was used as a substrate for
MMP activity as previously reported [22]. After electro-
phoresis, the gels were incubated and then stained with
Coomassie blue (BioRad). MMP activity was evident as
cleared bands of substrate lysis, with MMPs identified by
their molecular weights. The intensity of the bands was
quantitated by NIH image.
Western blotting
The Western blotting was performed following a previ-
ously described procedure [20,23]. Since a large amount
of protein is needed for Western blotting, the liver was used
for determination of the expression of signalling moleculesin insulin resistant rats. The rat livers were homoge-
nized in a freshly prepared lysis buffer and centrifuged
at 12,000g for 20 min at 4°C. Aliquots were run on 7.5-12%
separating and 4% stacking gels and electro-transferred
onto polyvinylidene fluoride membranes in transfer buf-
fer. Dilutions (1:1,000) of primary antibodies to insulin
receptor (IR), Tyr972-phosphorylated IR, insulin receptor
substrate-1 (IRS-1), Tyr612-phosphorylated IRS-1, adeno-
sine monophosphate-activated protein kinase (AMPKα),
Thr172-phosphorylated AMPKα, and GAPDH (Cell Signal-
ing Technology) were applied in blocking buffer. Goat anti-
rabbit or goat anti-mouse secondary antibody (1:2,000
dilutions) (Santa Cruz Biotechnology) was applied and
washed in TBS-Tween. Specific protein bands were
detected using Western Lightning PLUS-ECL Reagents
Plus (PerkinElmer Life and Analytical) and images were
captured by an imaging system (ChemiDoc™ XRS +
System, Bio-Rad). Relative band intensities were quanti-
fied using the Adobe Photoshop Program.
Measurement of mRNA levels in SMCs in vitro
SMCs were isolated from the injured carotid arteries by
enzymatic dispersion as described above [24]. SMCs were
grown in DMEM supplemented with 10% FCS and 2%
penicillin/streptomycin at 37°C with 5% CO2. Cells were
treated with fructose or MG with and without metformin.
Plating RNA was extracted by Trizol™ extraction (Invitrogen,
Carlsbad, CA), treated with DNase I to remove contam-
inating genomic DNA (Fermentas), and reverse tran-
scribed using the Superscript First-Strand Synthesis
System for RT-PCR (Invitrogen). Quantitative real-time
PCR (qRTPCR) reactions were performed using the ABI
7900 as described previously [24]. Primer sequences made





Each experiment was repeated independently 3 times, and
mRNA samples were assayed in triplicate.
Tissue contractility study
The tissue contractility study was conducted using a
procedure described previously in our laboratory [19].
In brief, carotid arteries were removed and placed in
cold physiological saline solution (PSS). The carotid
rings were carefully dissected and the vessel segments
(2.0 mm) were mounted in a four-channel wire myograph
(Multi myogragh, Model 610M, Denmark) aerated with a
gas mixture of 95%O2-5%CO2 at 37°C. Phenylephrine (PHE,
10-8 to 10-5 mol/L) was added cumulatively to generate a
PHE dose–response curves. The endothelium-dependent
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added cumulatively to generate the relaxation dose
responses.
Statistical analysis
Results are expressed as mean ± SD. All data were ana-
lyzed using analysis of variance (ANOVA). The difference
between the variances of the two groups was compared
using a two-tailed Student’s t test or one-way ANOVA
followed by a post hoc analysis (Tukey test). Statistical
significance was considered when P < 0.05.
Results
The effects of metformin on metabolic changes in insulin
resistant rats
The metabolic changes determined at 4 weeks after bal-
loon injury and following 4-week high fructose diet are
summarized in Table 1. Increased body weight was
observed in rats receiving high fructose diet, while treat-
ment with metformin prevented the gain of body weight
(Table 1). Blood glucose and insulin levels were elevated
in rats on the high fructose diet and treatment with
metformin improved glucose and insulin levels (Table 1).
Plasma total cholesterol and triglyceride levels were sig-
nificantly increased in the fructose group compared to
the controls and treatment with metformin improved
the lipid levels. LDL-cholesterol levels showed an in-
creasing trend with time while on the fructose diet, but
treatment with metformin reduced LDL-cholesterol levels
significantly. Free fatty acid levels were also highly in-
creased after fructose diet, but elevated free fatty acid
levels were improved in rats following treatment with
metformin (Table 1). Most notably, plasma MG levels
from the high fructose group were significantly increasedTable 1 Effects of metformin on metabolic changes in fructos
Chow control
Body weight (g) 514.0 ± 25.4
Liver weight (g) 13.8 ± 2.1
Heart weight (g) 1.5 ± 0.2
Kidneys weight (g) 3.1 ± 0.7
Mean BP (mmHg) 94.6 ± 10.9
Glucose (mmol/L) 5.80 ± 0.41
Insulin (μg/L) 0.14 ± 0.02
Cholesterol (mmol/L) 3.26 ± 0.22
HDL-C (mmol/L) 1.33 ± 0.05
LDL-C (mmol/L) 0.97 ± 0.08
Triglyceride (mmol/L) 2.10 ± 0.40
FFA (mmol/L) 0.77 ± 0.18
MG (nmol/L) 190.40 ± 52.94
*P < 0.05 vs. Chow control, **P <0.01 Fructose vs. Chow control.
†P < 0.05 vs. Fructose, ‡P < 0.01 vs. Fructose.
BP: blood pressure, HDL-C: high-density lipoprotein cholesterol, LDL-C: low-density
Determinations were performed 4 weeks after balloon injury following 4 week highcompared to those from the normal chow diet controls
(513.33 ± 58.29 vs. 190.40 ± 52.94 nmol/L, P < 0.01). Treat-
ment with metformin significantly reduced plasma MG
levels (Table 1). There were no significant differences in
metabolic changes between the chow group and the
chow group received metformin (data not shown).Metformin treatment attenuates neointimal formation in
fructose-induced insulin resistant rats
Neointimal hyperplasia occurred following balloon injury
(Figures 1A, B, and C). Neointimal hyperplasia remained
evident though metformin was administered to the group
of rats receiving chow diet (Figure 2B). The neointimal
hyperplasia of the carotid arteries (Figure 1D) was dra-
matically inhibited following treatment with metformin
compared with the untreated high fructose-fed rats at
4 weeks after balloon injury (Figure 1C). Morphometric
analysis indicated that treatment with metformin signifi-
cantly inhibited neointimal formation (0.010 ± 0.003 mm2,
cross-sectional area) in the carotid arteries compared
with untreated injured carotid arteries (0.03 ± 0.02 mm2,
P < 0.05, n = 8), determined 1 week after balloon injury
(Figure 1E). The intima/media ratio was also significantly
reduced at 1 week after balloon injury (0.26 ± 0.07 vs.
0.05 ± 0.04, P < 0.01) (Figure 1F). Similar inhibitory
effects on neointimal formation remained at 4 weeks after
balloon injury in the metformin-treated compared with
untreated groups (Figure 1G). The intima/media ratio
was also decreased at 4 weeks after balloon injury
(Figure 1H). There were no significant changes in media
area among the three groups at the different time points.
A chow control group also received balloon injury and
showed neointimal hyperplasia but to a lesser degreee-induced insulin resistant rats
Fructose diet (60%) Fructose +Metformin
554.0 ± 30.5* 517.2 ± 15.0†
18.0 ± 1.0 14.4 ± 2.2
2.1 ± 0.3 1.6 ± 0.1
4.7 ± 0.9 3.3 ± 0.5
93.1 ± 4.5 86.5 ± 9.2
6.32 ± 0.53* 5.24 ± 0.69‡
0.55 ± 0.22* 0.28 ± 0.02†
3.97 ± 0.18* 3.46 ± 0.22†
1.42 ± 0.23* 1.48 ± 0.29†
1.16 ± 0.12 0.82 ± 0.15†
3.27 ± 1.02** 2.56 ± 0.75†
2.00 ± 0.31** 1.17 ± 0.22‡
513.33 ± 58.29** 238.00 ± 42.00†

























































































Figure 1 Histological and morphometric changes of balloon injury-induced neointimal formation in insulin resistant rats. A) A representative
of the uninjured carotid artery in normal control rats. B) A representative of histological change 4 week after balloon injury, showing neointimal
hyperplasia in chow group treated with metformin. C) A representative of histological change of carotid artery 4 weeks after balloon injury, showing
severe neointimal hyperplasia in rats with high fructose diet. D) A representative of histologic change 4 weeks after balloon injury in rats with high
fructose diet and metformin administration (H&E staining, magnification x 100). Morphometric analyses on intimal area and intima to media ratio were
performed to quantitate neointimal hyperplasia at week 1 (E and F) and week 4 (G and H). *P < 0.05 vs. Chow control, †P < 0.05 vs. Fructose group.
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metformin did not show significant attenuation.
Antiproliferative effects of metformin on vascular SMCs
SMC proliferation was determined 7 days after carotid
artery injury (Figures 2A and B). Treatment with metformininduced a significant reduction in the percentage of
BrdU-positive cells in the neointima compared with
vehicle controls (18.4 ± 2.8% vs. 43.5 ± 5.2%, P < 0.01,
n = 6) (Figure 2D vs. Figure 2C). There was no significant
difference of BrdU-labeled positive cells in media area be-
tween the two groups (4.7 ± 0.6% vs. 5.8 ± 0.9%, P > 0.05).
A B
C D
Figure 2 Antiproliferative effect of metformin on vascular smooth muscle cells. BrdU-labeled nuclei are stained as dark brown. A: Uninjured;
B: Injured control; C: Fructose; D: Fructose +Metformin.
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change in the number of apoptotic cells in the neointima
between the two groups (data not shown).
The effect of metformin on SMC migration
The in vitro scratch assay revealed that both fructose
and MG significantly enhanced SMC migration compared
to the control group, as determined by wound closure at
24 hours (Table 2). The effect of fructose and MG on
SMC migration also behaved in a dose-dependent manner
(data not shown). Treatment with metformin for 24 hours
and 48 hours significantly attenuated the effects of fruc-
tose and MG on wound closure (P < 0.01). Data were
triplicates with three independent experiments.
The effect of metformin on MMP activity
Gelatin zymography showed enhanced MMP activities
as indicated by high activity of both MMP-9 (the top
band, 100 kDa) and MMP-2 (the lower band, 70 kDa) in
intimal SMCs treated with MG or fructose. Treatment
with metformin inhibited the MMP enzyme activities as




Fructose (30 mM) 0
Fructose (30 mM) + Metformin (10 mM) 0
MG (100 μM) 0
MG (100 μM) +Metformin (10 mM) 0
*P < 0.05 vs. 24 hr, **P < 0.01 vs. 24 hr.versus the untreated condition and the intensity of the
bands quantified by densitometer (P < 0.01 for MG +
metformin vs. MG and Fructose +metformin vs. Fructose,
respectively) (Figure 3A, B, and C). Similar MMP activities
and inhibitory effects of metformin on MMP activities
were also observed in medial SMCs treated with MG or
fructose (data not shown).
Expression of insulin signalling and inflammatory markers
in fructose-induced insulin resistant rats
There was no change in IR expression (Figure 4A) but
the phosphorylation of IR was decreased in the liver
(Figure 4B) following the 60% fructose diet and the de-
velopment of insulin resistance. Significant inhibition
of IRS-1, AMPKa, and their corresponding phosphory-
lated forms were observed in the liver by western blotting
(Figures C, D, E, and F). Treatment with metformin
reversed the inhibitory effects and significantly improved
the expression of these molecules including phosphory-
lated IR (P < 0.01) (Figures 4A, B, C, D, E, and F). There
were no significant differences in expression of these above
signalling molecules between the chow group and theSMC migration
Wound closure (%)
24 h 48 h
28.5 ± 1.3 82.2 ± 5.30**
54.1 ± 1.8 85.3 ± 1.9**
23.6 ± 1.1 73.6 ± 1.4*
83.4 ± 0.9 96.7 ± 1.4*

























































































Figure 3 Effects of metformin on MMP activity. Enhanced MMP activities were seen in intimal SMCs treated with MG or fructose in vitro
(Figure 3A). Treatment with metformin significantly inhibited the enzyme activity as observed through the relatively faint band and the reduced
intensity of the bands quantified by NIH image. Figures 3B and C indicate the relative density of MMP2 and MMP, respectively. MG + or Fructose +
in Figures 3B and C means co-treatment with metformin.
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addition, using an in vitro assay, real-time PCR revealed
that the expression of inflammatory markers JNK and
NFKB was markedly increased in MG or fructose treated
SMCs. Treatment with metformin attenuated this effect
on JNK and NFKB in SMCs (Figures 4G and H).
Improved vasoreactivity of carotids arteries by metformin
in insulin resistant rats
The vasocontraction of carotid artery, in response to
phenylephrine, increased in the experimental group 4
weeks after balloon injury as compared with uninjured
controls, though it did not achieve statistical significance
(Figure 5A). Treatment with metformin attenuated PHE-
induced vasoconstriction of the carotid artery compared
with that of the untreated rats (EC50 = 244 ± 29 nmol/L
vs. EC50 = 159 ± 27 nmol/L) (Figure 5A). The vasorelaxationof the carotid artery was severely impaired in fructose-fed
rats 4 weeks after balloon injury compared to the uninjured
controls (IC50 = 165 ± 7.6 nmol/L for the uninjured control)
(Figure 5B). Interestingly, treatment with metformin
improved methacholine-induced vasorelaxation in balloon
injured carotid arteries compared with untreated balloon
injured carotids (IC50 = 566 ± 44 nmol/L) (Figure 5B).
Discussion
High fructose intake has been shown to induce insulin
resistance, weight gain, and hyperlipidemia in animals
and humans [11]. In our study, insulin resistance developed
in SD rats following 8 weeks of feeding on a high fructose
diet. The animals experienced characteristic changes that
include increased body weight, glucose intolerance, in-
creased serum insulin levels, and dyslipidemia. Treatment














































































































































































































































Figure 4 Expression of insulin signalling and inflammatory markers in fructose-induced insulin-resistance in rats. There was no change
in IR expression (Figures 4A). Significant inhibition of p-IR, AMPK, p-AMPK, IRS-1, p-IRS was revealed in the liver in insulin resistant rats. Treatment
with metformin reversed the inhibitory effects and improved the expression of these molecules (Figures 4B, C, D, E, and F). Real-time PCR shows
increased expression of JNK and NFKB in MG or fructose treated SMCs (Figure 4G and H). Treatment with metformin attenuated this effect
(Figures G and H). * P < 0.05, ** P < 0.01 vs. the Chow control, ‡P < 0.01 vs. MG group, §P < 0.01 vs. Fructose group.
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supported by the evidence that metformin decreases
hepatic production of glucose and increases hepatic in-
sulin sensitivity and glucose clearance [25,26].
Insulin resistance is strongly associated with the develop-
ment of atherosclerosis and cardiovascular disease [1,2,27].
In our study, severe neointimal hyperplasia developed
following balloon injury in insulin-resistant rats com-
pared to normal chow controls. The neointimal hyper-
plasia observed was consistent with neointimal SMC
proliferation, suggesting SMC proliferation contributed
largely to the increased neointimal formation [28,29].
The neointimal hyperplasia of the carotid arteries wasdramatically inhibited following treatment with metfor-
min as compared with the untreated high fructose-fed
rats those were determined at 1 week and 4 weeks after
balloon injury. Neointimal SMC proliferation indicated
by BrdU-positive cells was also inhibited in the group
receiving metformin treatment. Metformin is known to
reduce the development of atherosclerotic lesions and
attenuate carotid intima-media thickness [18], but this
is the first time that a similar effect on balloon injury-
induced neointimal hyperplasia in insulin resistant rats
has been demonstrated. Moreover, our in vitro scratch
assay suggests that both fructose and MG-induced SMC
migration may contribute to the neointimal formation
BA
Figure 5 Improved vasoreactivity of carotids arteries by metformin in fructose-induced insulin-resistant rats. A) The vasocontraction of
the carotid artery in response to phenylephrine increased 4 weeks after balloon injury compared with uninjured controls in insulin-resistant rats
(■ injured carotids, □ uninjured carotids). Treatment with metformin attenuated the contraction (● ). B) Vasorelaxation was impaired and
treatment with metformin improved methacholine-induced vasorelaxation (■ injured without metformin, □ uninjured carotids, ● injured with
metformin) (n = 6 per group), *P < 0.05 vs. fructose group with injury, **P < 0.01 vs. fructose group with injury, #P < 0.05 vs. fructose group with
injury, ##P < 0.01 vs. fructose group with injury.
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could contribute beneficial effects by reducing stenosis.
Our in vitro experiment demonstrates that MMP activities
were significantly increased in fructose or MG-treated
SMCs. Treatment with metformin inhibited MMP activ-
ities. Previous studies have shown that MMP activity plays
a major role in matrix accumulation and neointimal for-
mation [24,30]. The observed inhibitory effect on MMP
activity and the upregulation of AMPK expression by
metformin in our study may suggest that the suppres-
sive effect on MMP is AMPK-dependent [31]. Taken
together, the increased SMCs proliferation, migration,
and MMP activity induced by fructose are likely to
contribute to the severe neointimal formation induced
by balloon injury in insulin-resistant rats. Thus, metformin
attenuated neointimal formation is mediated through
inhibition of SMCs proliferation, migration, and MMP
activity.
Plasma MG levels were highly increased in fructose-fed
rats, while treatment with metformin dramatically de-
creased the MG levels. This effect can be attributed to
metformin’s action as a scavenger of MG or through
normalization of metabolic abnormalities [17]. In a pre-
vious study, we have shown that fructose is the precur-
sor of MG [15]. Early research has also demonstrated
that MG induces insulin resistance and that treatment
with MG scavengers attenuates this effect in SD rats
[32,33]. Studies have shown that MG induces an inhibi-
tory effect on phosphorylation of IRS-1, PI3K activity,
and insulin-stimulated phosphorylation of protein kinase
B (PKB) and extracellular-regulated kinase ½ (ERK½) [23].
Metformin sensitizes insulin signalling through an AMP-activated protein kinase (AMPK)-mediated phosphatase
and tensin homolog (PTEN) down-regulation [34]. Our
findings show that the expression of AMPKa and IRS-1
was significantly down regulated in the liver in fructose-
induced insulin-resistant rats while treatment with met-
formin reversed this inhibitory effect. These findings
are consistent with metformin improving insulin signal-
ling probably through lowering of MG levels. Increased
expression of JNK and NFKB in SMCs suggests that
inflammation may play a role in the pathogenesis of
stenosis in fructose-induced insulin resistance and metfor-
min plays a protective role through the inhibition of
inflammatory pathway in insulin resistance and stenosis.
Vasorelaxation was severely impaired in balloon-catheter-
injured carotid arteries in insulin-resistant rats. Neverthe-
less, vasorelaxation was significantly restored in rats that
received treatment with metformin. We and others have
demonstrated that impairment of endothelium-dependent
vasorelaxation may be mediated by MG while metformin
treatment significantly improves endothelial function
and vasorelaxation [8,18,35-37]. These findings suggest
that the improvement of endothelial function and vessel
reactivity may be attributed to the effects of metformin
on reduction of MG levels and improvement of insulin
sensitivity [38]. Another study demonstrated that met-
formin reduces catecholamine-induced vasoconstriction
through endothelium dependent and independent mecha-
nisms in rats [39]. Demonstration of the vasoprotective
effect of metformin in an insulin resistant model has
not been previously reported.
In conclusions, this study has demonstrated that balloon-
injury-induced neointimal formation of the carotid arteries
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ment with metformin significantly attenuates balloon-
injury induced neointimal hyperplasia through inhib-
ition of SMC proliferation, migration, MMP activities,
and inflammation, as well as by improvement of the
insulin signaling pathway.
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